Megestrol acetate-induced adrenal insufficiency
✍ Scribed by Paula González Villarroel; Isaura Fernández Pérez; Concepción Páramo; Marta Gentil González; Beatriz Carnero López; M. Lidia Vázquez Tuñas; Juan A. Carrasco Álvarez
- Book ID
- 107596345
- Publisher
- Springer Milan
- Year
- 2008
- Tongue
- Spanish
- Weight
- 499 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1699-048X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. Adrenal suppression has been noted in patients who are receiving medroxyprogesterone acetate (MPA). Megestrol acetate (MA) is used to treat patients with advanced breast carcinoma, cachaexia related to acquired immune deficiency syndrome, and disseminated carcinomatosis, and it is be
## Abstract Patients with advanced cancer may develop cachexia, which is often treated with megestrol acetate (MA). In addition to thromboembolic disease, MA may cause symptomatic suppression of the hypothalamic pituitary adrenal axis. In male patients with cancer, treatment with MA may also suppre